semaglutide or tirzepatide weight loss and Injectable Correlated with Greatest Among GLP-1 Medications Semaglutide vs Tirzepatide for Weight

Starting at a lower Wegovy dose lets your body adjust to the different mechanism and reduces the risk of side effects

7 Other Eye Conditions Based on a study of 2,650 patients where 579 patients (21.84%) had secondary glaucoma, eye-related causes, in order of frequency, were post vitrectomy surgery, eye trauma, corneal pathology, aphakia, neovascular glaucoma, pseudophakia, and uveitis

Zepbound, an FDA-approved dual GLP-1 and GIP receptor agonist for chronic weight management, can produce significant results, but plateaus lasting 4-8 weeks are normal physiological responses

The potential risks stem from Ozempic's mechanism as a glucagon-like peptide-1 (GLP-1) receptor agonist